Clinical application of combination [<sup>11</sup>C]C-methionine and [<sup>13</sup>N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [<sup>18</sup>F]F-FDG PET/CT.

Authors:
Wang Z; Feng Z; Zhu D; Wang X; Chen J and 2 more

Journal:
BMC Endocr Disord

Publication Year: 2024

DOI:
10.1186/s12902-024-01543-2

PMCID:
PMC10840282

PMID:
38311763

Journal Information

Full Title: BMC Endocr Disord

Abbreviation: BMC Endocr Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study met the guidelines of the Declaration of Helsinki and was approved by the ethics committee of the First Affiliated Hospital, Sun Yat-Sen University. Written informed consent was obtained from all nine patients. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was founded by Guangzhou Science and Technology Project (No. 202102021116 and No. 202201010307), National Natural Science Foundation of China for Young Scholars (No. 81802678), The Natural Science Foundation of Guangdong Province, China (No.2018A030310107), Medical Science and Technology Research Foundation of Guangdong Province, China (No.2018558), Sun Yat-sen University Clinical Research 5010 Program (No. 2016008)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025